abstract |
The present invention relates generally to methods of treating brain diseases and to compounds for treating brain diseases, and more particularly to proteins belonging to the Rap family of small GTPases for treating diseases of the brain such as Alzheimer's disease and schizophrenia. It relates to the use of compounds capable of modulating guanine base regulators for. |